Table 3 Detailed information of patients who experienced tumour relapse or death
Characteristics | Patientsa | ||||||||
|---|---|---|---|---|---|---|---|---|---|
P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | |
Age, months | 7 | 24 | 9 | 5 | 19 | 41 | 46 | 6 | 87 |
AFP at diagnosis | 50,000 | 10.6 | 24,200 | 80,000 | 252.5 | 80,000 | 1,000,000 | 82,480 | 5000.08 |
PRETEXT stage | II | III | II | II | IV | II | Null | Null | II |
Multifocal tumour | No | No | No | No | Yes | No | Null | Null | No |
Metastasis | Yes | Yes | No | Yes | Yes | No | Null | Null | No |
Neoadjuvant chemotherapy, cycles | 0 | 2 | 0 | 8 | 4 | 4 | 2 | 0 | 0 |
Preoperative TACE | 0 | 2 | 3 | 0 | 7 | 1 | 4 | 5 | 0 |
POSTTEXT stage | – | III | II | II | III | II | Null | Null | – |
Surgical margin statusb | N− | P+ | N− | N− | P+ | N− | Null | Null | N− |
Postoperative pathologic subtypec | Foetal | With TF | EV | MEM | EV | EM | Null | Null | EM |
Postoperative chemotherapy, cycles | 3 | 0 | 6 | 4 | 2 | Null | Null | 4 | 4 |
Relapse site | lung | lung | lung | liver, lung | liver, lung | lung | liver | liver | liver |
Death | Yes | Yes | Yes | Yes | No | No | No | No | No |
Time from diagnosis to death, months | 7.7 | 3.6 | 21.4 | 14.8 | – | – | – | – | – |